DETECTION OF P53 MUTATIONS BY SINGLE-STRAND CONFORMATION POLYMORPHISMS (SSCP) GEL-ELECTROPHORESIS - A COMPARATIVE-STUDY OF RADIOACTIVE AND NONRADIOACTIVE SILVER-STAINED SSCP ANALYSIS

被引:56
作者
BOSARI, S
MARCHETTI, A
BUTTITTA, F
GRAZIANI, D
BORSANI, G
LODA, M
BEVILACQUA, G
COGGI, G
机构
[1] OSPED MAGGIORE,IRCCS,DEPT ANAT PATOL 2,MILAN,ITALY
[2] UNIV PISA,SCH MED,INST PATHOL ANAT & HISTOL,I-56100 PISA,ITALY
[3] HARVARD UNIV,SCH MED,BOSTON,MA
[4] DEACONESS HOSP,DEPT PATHOL,BOSTON,MA
[5] UNIV MILAN,SCH MED,DEPT PATHOL,I-20122 MILAN,ITALY
关键词
P53; PCR; RADIOACTIVE SINGLE-STRAND CONFORMATION POLYMORPHISMS; NONRADIOACTIVE SINGLE-STRAND CONFORMATION POLYMORPHISMS;
D O I
10.1097/00019606-199512000-00004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
p53 mutations are the most common genetic abnormality in human tumors, but their clinical significance remains to be precisely elucidated. Conventional single-strand conformation polymorphism (SSCP) analysis, a well-established technique for detecting p53 mutations, uses radioactively labeled polymerase chain reaction (PCR) products, which migrate abnormally in the presence of mutations. We performed radioactive PCR-SSCP analysis in a series of 30 formalin-fixed, paraffin-embedded ovarian carcinomas and two cell lines (SW480 and Caov4) harboring known homozygous p53 mutations and compared the results with nonradioactive silver-stained SSCP. The purpose was to assess whether nonradioactive SSCP is suitable for detecting p53 mutations in a rapid, sensitive, cost-effective fashion, without the need of radioactive isotopes. We accomplished PCR amplification of p53 exons 5 through 8 in 26 carcinomas, and radioactive SSCP detected p53 mutations in 13 tumors: three mutations were localized in exon 5, six in exon 6, two in exon 7, and two in exon 8. All mutations were correctly identified with nonradioactive SSCP, except for one exon 8 mutation. To establish the sensitivity of nonradioactive SSCP, DNA samples of SW480 and Caov4 were mixed with increasing amounts (0-90%) of normal DNA and subjected to PCR-SSCP analysis. Mutations were detected until the concentration of SW480 and Caov4 was 15% and 10%, respectively, of the total sample, The results of our investigation demonstrate that nonradioactive silver-stained SSCP is a sensitive, rapid, and Simple technique to detect p53 mutations, even in formalin-fixed tissues, and could be easily used to investigate large series of patients to assess the clinical significance of p53 mutations in human tumors.
引用
收藏
页码:249 / 255
页数:7
相关论文
共 54 条
  • [1] DIAGNOSTIC SINGLE-STRAND CONFORMATIONAL POLYMORPHISM, (SSCP) - A SIMPLIFIED NONRADIOISOTOPIC METHOD AS APPLIED TO A TAY-SACHS-B1 VARIANT
    AINSWORTH, PJ
    SURH, LC
    COULTERMACKIE, MB
    [J]. NUCLEIC ACIDS RESEARCH, 1991, 19 (02) : 405 - 406
  • [2] ASSOCIATION OF P53 PROTEIN EXPRESSION WITH TUMOR-CELL PROLIFERATION RATE AND CLINICAL OUTCOME IN NODE-NEGATIVE BREAST-CANCER
    ALLRED, DC
    CLARK, GM
    ELLEDGE, R
    FUQUA, SAW
    BROWN, RW
    CHAMNESS, GC
    OSBORNE, CK
    MCGUIRE, WL
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (03) : 200 - 206
  • [3] IMMUNOHISTOCHEMICAL DETECTION OF P53 PROTEIN IN MAMMARY-CARCINOMA - AN IMPORTANT NEW INDEPENDENT INDICATOR OF PROGNOSIS
    BARNES, DM
    DUBLIN, EA
    FISHER, CJ
    LEVISON, DA
    MILLIS, RR
    [J]. HUMAN PATHOLOGY, 1993, 24 (05) : 469 - 476
  • [4] BARTEK J, 1991, ONCOGENE, V6, P1699
  • [5] BEAHRS OH, 1992, MANUAL STAGING CANCE
  • [6] BODNER SM, 1992, ONCOGENE, V7, P743
  • [7] ABNORMAL P53 IMMUNOREACTIVITY AND PROGNOSIS IN NODE-NEGATIVE BREAST CARCINOMAS WITH LONG-TERM FOLLOW-UP
    BOSARI, S
    LEE, AKC
    VIALE, G
    HEATLEY, GJ
    COGGI, G
    [J]. VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1992, 421 (04) : 291 - 295
  • [8] CYTOPLASMIC ACCUMULATION OF P53 PROTEIN - AN INDEPENDENT PROGNOSTIC INDICATOR IN COLORECTAL ADENOCARCINOMAS
    BOSARI, S
    VIALE, G
    BOSSI, P
    MAGGIONI, M
    COGGI, G
    MURRAY, JJ
    LEE, AKC
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (09): : 681 - 687
  • [9] CALEFFI M, 1994, CANCER, V73, P2147, DOI 10.1002/1097-0142(19940415)73:8<2147::AID-CNCR2820730820>3.0.CO
  • [10] 2-5